Large-scale testing (Phase 3)Ended earlyNCT03419403What this trial is testingUNITE Study: Understanding New Interventions With GBM ThErapyWho this might be right forGlioblastoma Multiforme AbbVie 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758062What this trial is testingLevetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype GlioblastomaWho this might be right forGlioblastoma Tianjin Medical University General Hospital 140
Early research (Phase 1)Active Not RecruitingNCT04521686What this trial is testingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsWho this might be right forCholangiocarcinomaChondrosarcomaGlioma+1 more Eli Lilly and Company 200
Early research (Phase 1)Active Not RecruitingNCT05226494What this trial is testingSafety and Tolerability of Fb-PMT in Recurrent GlioblastomaWho this might be right forGlioma, Malignant NanoPharmaceuticals LLC 34
Testing effectiveness (Phase 2)Temporarily pausedNCT06329570What this trial is testingSafety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)Who this might be right forGlioblastoma MultiformeGlioblastomaGlioma+3 more NaviFUS Corporation 10
Testing effectiveness (Phase 2)Study completedNCT01977677What this trial is testingPlerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade GliomaWho this might be right forAdult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more Lawrence Recht 30
Testing effectiveness (Phase 2)Study completedNCT01120639What this trial is testingPhase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformWho this might be right forGlioblastomaCancer of Brain and Nervous SystemGlioblastoma Multiforme Stanford University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939What this trial is testingStudy of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) PatientsWho this might be right forGlioblastoma Institut de cancérologie Strasbourg Europe 554
Early research (Phase 1)Active Not RecruitingNCT03011671What this trial is testingStudy of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant GliomaWho this might be right forMalignant Glioma of Brain University of Chicago 10
Early research (Phase 1)Looking for participantsNCT05686798What this trial is testingAdenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.Who this might be right forMalignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more Henry Ford Health System 18
Not applicableLooking for participantsNCT06533163What this trial is testingLow-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot TrialWho this might be right forGlioblastoma Multiforme BioTex, Inc. 30
Early research (Phase 1)Study completedNCT00002753What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Recurrent GliomasWho this might be right forBrain and Central Nervous System Tumors Duke University 6
Early research (Phase 1)Study completedNCT01800695What this trial is testingEvaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme AbbVie 202
Testing effectiveness (Phase 2)Study completedNCT00612339What this trial is testingAvastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and GliosarcomasWho this might be right forGlioblastomaGliosarcoma Duke University 41
Early research (Phase 1)Looking for participantsNCT07145112What this trial is testingLaser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent GlioblastomaWho this might be right forGlioblastoma University of California, Davis 20
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Not applicableStudy completedNCT02410577What this trial is testing89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)Ended earlyNCT03393000What this trial is testingSafety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only SubjectsWho this might be right forGlioblastoma Diffusion Pharmaceuticals Inc 19
Not applicableStudy completedNCT03926507What this trial is testingF18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing SurgeryWho this might be right forGlioblastoma M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01011231What this trial is testingStudy of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent GliomaWho this might be right forGlioblastoma University of California, San Francisco 1